{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:26:27Z","timestamp":1789586787224,"version":"build-2803163510"},"reference-count":28,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2014,7,30]]},"abstract":"<jats:p>A 36-year-old man with type 1 diabetes developed skin inflammation at the site of subcutaneous insulin injection after 10\u2005years of basal bolus subcutaneous insulin therapy. This inflammation led to poor insulin absorption, poorly controlled blood glucose and subsequently to ketoacidosis. The problem persisted despite a trial of continuous subcutaneous insulin infusion. The patient went on to be treated with continuous intraperitoneal insulin infusion. Three months after the procedure, he was achieving good glucose control and was able to resume his normal life, with the only complication being an episode of cellulitis surrounding the port site.<\/jats:p>","DOI":"10.1136\/bcr-2014-205278","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T08:39:22Z","timestamp":1408610362000},"page":"bcr2014205278","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Intraperitoneal insulin therapy for a patient with type 1 diabetes with insulin injection site inflammation"],"prefix":"10.1136","volume":"2014","author":[{"given":"Siang Ing","family":"Lee","sequence":"first","affiliation":[{"name":"The Queen Elizabeth Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth","family":"Narendran","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Medicine, The Medical School, University of Birmingham, UK"},{"name":"Department of Diabetes, The Queen Elizabeth Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,8,21]]},"reference":[{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.1","unstructured":"NHS Choices. Pancreas transplant. http:\/\/www.nhs.uk\/conditions\/pancreastransplant\/Pages\/Introduction.aspx (updated 14 May 2012; accessed 3 Mar 2014)."},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.2","unstructured":"NHS Blood and Transplant. Organ donation. Activity report 2012\u20132013, Section 11\u2014Survival rate following transplant. http:\/\/www.organdonation.nhs.uk\/statistics\/transplant_activity_report\/ (accessed 5 Mar 2013)."},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.3","unstructured":"Bellew M . Cases of lung cancer reported in clinical trials of inhaled insulin (Exubera). NPC Rapid Review. http:\/\/www.npc.nhs.uk\/rapidreview\/?p=108 (updated 6 May 2008; accessed 5 Mar 2014)."},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.4","doi-asserted-by":"publisher","DOI":"10.3310\/hta11030"},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.5","unstructured":"CADTH. Afrezza inhaled insulin for diabetes mellitus. http:\/\/www.cadth.ca\/en\/products\/environmental-scanning\/issues-in-emerging-health-technologies\/eh0003-inhaledinsulin (updated June 2013; accessed 5 Mar 2014)."},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.6","unstructured":"Diabetology. Oral insulin. http:\/\/www.diabetology.co.uk\/oral (cited 5 Mar 2014)."},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.7","unstructured":"Roche HL . Evaluation of Accu-Chek DiaPort, a Port System for Continuous Intraperitoneal Insulin Infusion, in Patients With Type I Diabetes. http:\/\/clinicaltrials.gov\/show\/NCT01483352 (updated 15 Aug 2012; accessed 18 Feb 2014)."},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.8","unstructured":"Diabetes Health. Diaport gets European approval\u2014permanent catheter system would be one component of artificial pancreas. http:\/\/diabeteshealth.com\/read\/2000\/12\/01\/2056\/diaport-gets-european-approvalpermanent-catheter-system-would-be-one-component-of-artificial-pancrea\/ (accessed 5 Mar 2014)."},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.9","unstructured":"Jordan L . Using a Diaport. Insulin-Pumpers UK. http:\/\/www.insulin-pumpers.org.uk\/diaport\/ (updated 18 July 2005; accessed 18 Feb 2014)."},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.10","doi-asserted-by":"publisher","DOI":"10.2337\/diab.41.6.657"},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.11","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(81)90164-5"},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.12","doi-asserted-by":"publisher","DOI":"10.1530\/EC-13-0089"},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.13","doi-asserted-by":"publisher","DOI":"10.1007\/BF00258308"},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.14","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1758"},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.15","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-2340"},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.16","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2010.0209"},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-014-0557-3"},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.18","unstructured":"Medical Research Foundation. Intraperitoneal vs Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus (IPvsSC). http:\/\/clinicaltrials.gov\/show\/NCT01621308 (updated 14 Oct 2013; accessed 18 Feb 2014)."},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.19","unstructured":"Medtronic Diabetes. Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration (MIP310). http:\/\/clinicaltrials.gov\/show\/NCT00211536 (updated 19 Sep 2011 September 19; accessed 18 Feb 2014)."},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.20","doi-asserted-by":"publisher","DOI":"10.1016\/S1262-3636(07)70075-7"},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.21","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199210000-00011"},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.22","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.15.7.877"},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.23","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v3.i8.142"},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.24","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2002.00727.x"},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2009.00572.x"},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2009.00612.x"},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.27","doi-asserted-by":"publisher","DOI":"10.1016\/S1262-3636(07)70069-1"},{"key":"2025082803243399000_2014.aug21_1.bcr2014205278.28","doi-asserted-by":"publisher","DOI":"10.1016\/S1262-3636(07)70221-5"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2014-205278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:24:46Z","timestamp":1756376686000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2014-205278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,21]]},"references-count":28,"alternative-id":["10.1136\/bcr-2014-205278"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2014-205278","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,21]]}}}